Eagle Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,506,284
| Closed | -$22.9M | – | 683 |
|
|
2019
Q4 | $22.9M | Buy |
4,506,284
+2,190
| +0% | +$11.1K | 0.11% | 222 |
|
|
2019
Q3 | $22.8M | Buy |
4,504,094
+4,386
| +0.1% | +$22.2K | 0.12% | 220 |
|
|
2019
Q2 | $27.8M | Sell |
4,499,708
-8,722
| -0.2% | -$53.8K | 0.14% | 210 |
|
|
2019
Q1 | $20.9M | Buy |
4,508,430
+13,065
| +0.3% | +$60.6K | 0.11% | 222 |
|
|
2018
Q4 | $18.9M | Buy |
4,495,365
+50,692
| +1% | +$213K | 0.12% | 217 |
|
|
2018
Q3 | $27.9M | Sell |
4,444,673
-16,809
| -0.4% | -$105K | 0.13% | 221 |
|
|
2018
Q2 | $35.9M | Sell |
4,461,482
-9,356
| -0.2% | -$75.2K | 0.19% | 189 |
|
|
2018
Q1 | $33.4M | Buy |
4,470,838
+310,078
| +7% | +$2.31M | 0.18% | 186 |
|
|
2017
Q4 | $24.6M | Sell |
4,160,760
-6,159
| -0.1% | -$36.5K | 0.14% | 224 |
|
|
2017
Q3 | $32.2M | Buy |
4,166,919
+154,553
| +4% | +$1.19M | 0.18% | 191 |
|
|
2017
Q2 | $27.2M | Buy |
4,012,366
+1,352,245
| +51% | +$9.18M | 0.16% | 205 |
|
|
2017
Q1 | $25.1M | Sell |
2,660,121
-5,143
| -0.2% | -$48.5K | 0.16% | 194 |
|
|
2016
Q4 | $23M | Buy |
+2,665,264
| New | +$23M | 0.15% | 201 |
|